days after the selective intra-arterial administration of reserpine revealed no differences in normal subjects but substantially decreased vasospasm in patients with Raynaud's syndrome. CHA with postreserpine studies was found to be diagnostically useful in Raynaud's syndrome, revealing the degree of organic arterial disease and functional vasospasm. In addition, correlation of postreserpine studies with observed clinical responses to long-term vasodilator drug therapy indicated that CHA has a good chance to predict the probable outcome of such therapy in Raynaud's syndrome.
clinical and laboratory evaluation, including a standardized cold exposure digital temperature test, multiple immunologic studies and skin biopsy.52 In fifteen of the 39 affected patients, Raynaud's symptoms were classified as mild (occasional attacks of digital vasospasm not exceeding two to three attacks per week in cool weather, nonprogressive, with minimal functional impairment); in 12 as moderate (daily attacks in cool weather with some progression and moderate functional impairment), and in 12 as severe (frequent attacks with significant progression and evidence of previous or current ulcerations). Of the eight volunteers without Raynaud's symptoms who were studied in order to establish the normal angiographic response to cold exposure, five (mean age 31 years and range 24 to 35 years) had no atherosclerosis, while three (mean age 65 years and range 58 to 74 years) did.
Method
The study was done in a warm room (20 to 220 C) with the subject well covered; the examined hand was kept in direct contact with the subject's body until the injection, to avoid hypothermia. First a baseline (resting) angiogram was done at the subject's usual skin temperature at the fingertips, as determined prior to the procedure by a thermistor probe. About 10 minutes later, after reviewing films from the first study, the subject's hand and distal forearm were immersed for 20 seconds in a plastic bag filled with an ice-water mixture. During the immersion, the subject moved his fingers. Immediately afterwards, the hand was blotted dry and a cold exposure (ice) angiogram was performed. Nineteen subjects also had a rewarm angiogram, which was done 5 minutes (nine subjects) or 10 minutes (ten subjects) after the cold exposure angiogram. Between these angiograms, the hand rested on a pad at room temperature. In 36 subjects, one hand (in Raynaud's syndrome the more symptomatic one) was examined. Nine subjects had studies of both hands.
Following the study, in all patients with Raynaud's syndrome and in two of the volunteers without it, reserpine (0.5 mg) was selectively injected into the brachial artery prior to removal of the catheter. Forty-eight hours later, follow-up (postreserpine) studies were done on 32 subjects, 30 with Raynaud's syndrome and two without it ( Postreserpine study done 48 hours after the initial examination in 30 patients of this group showed no basal vasospasm on the baseline angiograms in eight patients, including four who had not had vasospasm on the prereserpine studies and four others whose original basal vasospasm had a mean grade of 1.5. Basal vasospasm also substantially decreased in the majority of the other 22 patients (table 2, fig. 2D ). The average postreserpine basal vasospasm grade of 0.5 reflected a mean decrease of 0.7 in comparison with prereserpine studies (fig. 6 ). On the cold exposure angiograms after reserpine, the cryogenic vasospasm fig. 6 ). The differences in degree of vasospasm on prereserpine and postreserpine studies were found to be statistically significant (P < 0.05).
In correlating CHA findings with results of long-term therapy with oral guanethidine and phenoxybenzamine, 3' 12 no relation was found between its outcome and degree of organic arterial disease and degree of basal or cryogenic vasospasm on the initial prereserpine study (table 3) . The postreserpine study, and in particular the decrease in degree of both the basal and cryogenic vasospasm, however, showed to be a good indicator of the therapeutic outcome (table 3, fig. 7 ). At a one year mean follow-up period, 11 patients who judged their therapeutic results as excellent, with complete subsidence of Raynaud's symptoms, had a mean decrease of basal vasospasm of 1.1 (range 0.5-2.5), cryogenic vasospasm of 1.9 (range 1-2.5) and a fast return to baseline angiographic appearance ( fig. 2) . Fourteen Digital temperature recovery times were abnormal in 38 of the 39 patients with Raynaud's syndrome, averaging 33 and ranging from 20 to 45 minutes. The other patient had an initial temperature recovery time of 10 minutes. The temperature recovery time was determined during treatment in 32 patients; in 27 it returned to normal, while in the other five it decreased substantially.
Discussion
No effort was made to differentiate between Raynaud's disease, phenomenon, and/or syndrome, categorizations which have caused confusion. Immunologic evaluation suggests that in most patients, Raynaud's symptoms are secondary to autoimmune or other immunological aberrations and therefore should be classified as Raynaud's syndrome. 12 In the past, hand angiography has been mostly done by puncture of the brachial artery, a technique which often vasospasm, abnormally high and persistent vasospastic response to cold with a substantial decrease in functional changes 48 hours after intra-arterial reserpine administration. Organic obstructive disease was present in 87% of our patients involving mainly digital arteries, and particularly the proper digital arteries which often showed multiple occlusions. Major vessels were also involved, with the ulnar artery showing more advanced changes than the radial artery. Basal vasospasm evident on baseline angiograms of 90% of our patients with Raynaud's syndrome ranged from diffuse narrowing of proper digital arteries to severe constriction of common digital arteries with attenuation of palmar arches and apparent absence of distal flow. This wide range of spastic changes, the lack of their correlation with clinical symptoms, as well as the presence of advanced spasm with no distal visualization, even in patients with almost normal resting digital skin temperatures, suggest that the severity of angiographically visualized basal vasospasm is an inconstant reflection of the response of hyperactive hand arteries to angiographic procedural stress, a response which differs widely in individual patients. The improvement in vasospasm which we observed following selective intraarterial reserpine, as well as the reportedly lower incidence of spasm on angiograms done under general anesthesia,6' 10 support this hypothesis.
Vasoconstriction associated with cold exposure is a functional, physiological response, and in our experience appeared despite general anesthesia or selective reserpine administration. Normally, the response is of short duration and disappears in 5 to 10 minutes. It vasoconstriction ranges from diffuse attenuation of the proper digital arteries to their complete constriction with narrowing of common digital arteries. In patients with Raynaud's syndrome, the cryogenic response superimposed on basal vasospasm results in more advanced spasm and sometimes completely constricts even palmar arches. The cryogenic vasospasm persists for a long period and in our series we saw no or little change in its degree on angiograms done 5 to 10 minutes after cold exposure. The intra-arterial administration of reserpine does not influence the appearance or degree of normal cold-elicited vasoconstriction; however, it reduces the severity and duration of the pathologic vasospasm seen at rest and after cold exposure in patients with Raynaud's syndrome. Intraarterial reserpine, acting as a neuronal norepinephrine depleter, causes a regional sympathetic blockade, alleviates vasoconstrictor activity and increases nutritive blood flow. Its action is prolonged, and animal studies have shown that a single intra-arterial injection depletes norepinephrine for about 14 days. '6 CHA, particularly the information gained from the rewarming angiograms, was accurate in the diagnosis of Raynaud's syndrome. It was clearly positive in all of our patients with Raynaud's syndrome, even one whose cold exposure digital temperature test was borderline normal. The diagnosis of Raynaud's syndrome, however, is usually easily made clinically and with the use of noninvasive methods. The major contribution of CHA relates to quantitating the disease and, in our belief, to predicting the therapeutic results. Baseline prereserpine angiograms show the degree of basal vasospasm and occasionally the extent of organic involvement of the hand arteries; cold exposure angiograms reveal the character of vasospastic response. Postreserpine studies provide detailed information about obstructive arterial disease and appear to afford means for predicting the results of therapy decreasing sympathetic activity. According to our experience, when such studies show a substantial decrease of basal and cryogenic vasospasm, good results can be expected. With diminishing relief of vasospasm after reserpine, the therapeutic expectation seems to be proportionally less favorable. Even when our results showed statistical significance, further studies on more patients with longer follow-up periods will be necessary to provide the final answer about the prognostic value of CHA in the management of Raynaud's syndrome.
